Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020

Main Article Content

Clement Drew
Asri C Adisasmita

Abstract

Penyakit oleh virus SARS-CoV2 yang menyerang sistem pernapasan telah menjadi pandemi sejak Februari 2020 dan di Indonesia sejak Maret 2020. Penting untuk mengidentifikasi faktor risiko yang meningkatkan risiko mortalitas dalam kasus ini. Studi analitik dengan desain kohort retrospektif dari data penelusuran epidemiologis oleh Dinas Kesehatan Provinsi DKI Jakarta di Jakarta Timur sejak bulan Maret - September 2020. Dari total data yang didapatkan (8393 sampel), terdapat 212 (2.53%) orang yang meninggal. Analisis data multivariat dengan regresi logistik menemukan bahwa jenis kelamin laki-laki meningkatkan RR mortalitas sebesar 2.15 (95% IK: 1.47-3.14), usia ?60 tahun sebesar 4.49 (95% IK: 3.05-6.63), adanya gejala saluran pernapasan sebesar 2.17 (95% IK: 1.26-3.72), adanya gejala luar saluran pernapasan sebesar 2.47 (95% IK: 1.43-4.29), riwayat hipertensi sebesar 2.45 (95% IK: 1.46-4.10) dan riwayat gagal ginjal kronik sebesar 3.33 (95% IK: 1.27 - 8.68). Dari hasil studi ini dapat disimpulkan bahwa jenis kelamin, usia, gejala saluran pernapasan, gejala luar saluran pernapasan, riwayat hipertensi dan gagal ginjal kronik meningkatkan risiko mortalitas pasien positif COVID-19 di Jakarta Timur.

Article Details

Section
Artikel Asli
Author Biographies

Clement Drew, FK Univ. Tarumanagara

Ilmu Kesehatan Masyarakat

Asri C Adisasmita, FK Univ. Indosia

Departemen epidemiologi FKM UI

References

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. May 2020;109:102433.

Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis and control of COVID-19. Viruses. Mar 2020;12(4): 372.

Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. May 2020;13(5):667-73.

Shi Y, Wang G, Cai X. et al. An overview of COVID-19. J Zhejiang Univ Sci B. May 2020;21(5):343-60.

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet. Infectious diseases. May 2020;20(5):533–4.

Dinas Kesehatan DKI Jakarta. (2020). Data Pemantauan Covid-19 DKI Jakarta. Diakses dari: https://corona.jakarta.go.id/id/data-pemantauan.

Akbar J. Perjalanan Pandemi Covid-19 di Indonesia, Lebih dari 100.000 Kasus dalam 5 Bulan. [Internet] Kompas.com.2020

Satgas COVID-19 Indonesia. (2020). ‘Peta Sebaran COVID-19 di Indonesia’ Diakses di: https://covid19.go.id/peta-sebaran. 2020.

Baron S, Fons M, Albrecht T. Viral Pathogenesis. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 45. Available from: https://www.ncbi.nlm.nih.gov/books/NBK814 9

Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e. New York, NY: McGraw-Hill. 2020.

Noor FM, Islam MM. Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis. J Community Health. Dec 2020;45(6):1270-82.

Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID 19: Are males more vulnerable?. Biol sex Differ. 2020;11:53.

Bonanad C, Blas SG, Santabalbina FT, et al. The effect of age on mortality in patients with COVID-19: A meta-analysis with 611,583 subjects. Journal of the American Medical Directors Association. Jul 2020;21(7):915-8.

Liang X, Shi L, Wang Y, et al. The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates. J Infect. Sep 2020;81(3):e44-47.

Wang X, Fang X, Cai Z, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity aand mortality among COVID-19 patients: A systemic review and meta-analysis. Research (Wash DC). Apr 2020;2402961.

Drager LF, Abreu AP, Bortolotto LA, et al. Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic?. Curr Hypertens Rep. 2020;22(6):43.

Pititto BA, Dualib PM, Zajdenverg L, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetology & Metabolic Syndrome. Aug 2020, 12(1):75.

Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. May 2020:1-14.

Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study. Eur Respir J. May 2020;55(5):2000524.

Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. Jul 2020;584(7821):430–6.

Gasparini M, Khan S, Patel JM, et al. Renal impairment and its impact on clinical outcomes in patients who are critically ill with COVID-19: a multicentre observational study. Anaesthesia. Oct 2020;76(3):320-6.

Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. March 2020; 2000547[14p].

Mehra MR, Desai SS, Kuy SR, Henry TD. Cardiovascular disease, drug therapy and mortality in Covid-19. N Engld J Med Jun 2020;382:e102.